Faculty Panel Q&A: Part 1 - 2021

3.67 (3 votes)

  • Register
    • Non-Member - $39
    • Regular Member - $29
    • Retired - $29
    • Early Career Physician - $29
    • Resident - $19
    • Student - $19
    • Associate - $19
    • ASAM Staff - Free!
    • International Member - $29
    • Emeritus Member - $29
    • Provisional Member - $29
    • Fellow Member - $29
    • Honorary Member - $29
    • CRT Member - $29

Faculty Panel Q&A: Part 1

Recorded: Thursday, July 22, 2021 - Saturday, July 24, 2021
On-Demand Session


This 60-minute, on-demand session from the ASAM 2021 Review Course provides answers to the top questions asked during Faculty presentations covering a variety of topics from the Neurobiology of Addiction to all other recognized Substance Use Disorders and Behavioral Addictions. 

This panel session is the prime opportunity for learners to get their questions answered on topics that were presented on the first day of the ASAM Review Course. 

Session Topics Being Discussed:  
-Neurobiology of Addiction: Key Concepts and Model
-Alcohol Use Disorder: From Neurobiology to Treatment
-Sedative Use Disorder: Key Concepts for Treatment
-Opioid Use Disorder: Science, History, and Clinical Implications
-Tobacco Use Disorder: Trends and Treatment
-Cannabis Use Disorder: Science, Trends and Clinical Implications
-Stimulant Use Disorder: Trends and Treatment
-Other Classes of Drugs: Pharmacology and Epidemiology
-Behavioral Addiction: From Theory to Treatment

The target audience for this introductory and intermediate level activity includes: Physicians preparing for the ABPM or AOA Board Certification Examination in addiction medicine, nurse practitioners, physician assistants, other clinicians, researchers, residents, fellows, students, and counselors.

This activity addresses the following ACGME Competencies: Patient Care, Medical Knowledge, Interpersonal and Communication Skills, and Practice-Based Learning and Improvement.

Learning Objectives

Upon completion, learners will be able to:

  1. Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting
  2. Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals
  3. Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders
  4. Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient
  5. Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse

Registration Rates

ASAM Learner TypeRate
ASAM Member$29
Associate Member$19
Resident Member*$19
Student Member*$19

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM e-Learning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 08/09/2024


  1. Click on the Contents tab to begin this activity.
  2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 2 out of 3 questions correctly.
  3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
  4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Petros Levounis


Petros Levounis, MD, MA, DFASAM serves as professor and chair of the Department of Psychiatry and Associate Dean for Professional Development at Rutgers New Jersey Medical School. Dr. Levounis came to Rutgers from Columbia University where he served as director of the Addiction Institute of New York from 2002 to 2013.

Dr. Levounis is a Phi Beta Kappa graduate of Stanford University where he studied chemistry and biophysics before receiving his medical education at Stanford University School of Medicine and the Medical College of Pennsylvania. During medical school, he researched the effects of social class on patient-physician relationships in Oxford, England, and received an MA degree in sociology from Stanford. In 1994, he moved to New York City to train in psychiatry at the New York State Psychiatric Institute of Columbia University. He graduated from Columbia earning the National Institute of Mental Health Outstanding Resident Award and went on to complete his fellowship in addiction psychiatry at New York University.

Dr. Levounis has written numerous articles, monographs, and book chapters; has lectured extensively on addiction topics throughout the United States and abroad; and has been interviewed by CBS, ABC, NBC, CNN, FOX, The Martha Stewart Radio Show, The New York Times, and The Washington Post, among others.

Dr. Levounis has served on the boards of the American Society of Addiction Medicine (ASAM) and the American Board of Addiction Medicine, and from 2005 to 2009 chaired the national Committee on Addiction Treatment of the American Psychiatric Association (APA). Dr. Levounis is a Betty Ford Scholar, a recipient of the Association of Gay and Lesbian Psychiatrists’ Distinguished Service Award and the ASAM Educator of the Year Award, and a distinguished fellow of the APA and ASAM. In 2017, he was elected as an honorary member of the World Psychiatric Association.

Dr. Levounis has published thirteen books including the self-help paperback “Sober Siblings: How to Help Your Alcoholic Brother or Sister—and Not Lose Yourself,” the textbook of “Substance Dependence and Co-Occurring Psychiatric Disorders,” “Motivational Interviewing for Clinical Practice,” “The Behavioral Addictions,” “Becoming Mindful,” “Pocket Guide to LGBTQ Mental Health,” and “Office-Based Buprenorphine Treatment of Opioid Use Disorder,” now in its second edition. Dr. Levounis is currently working on the first textbook of Technological Addictions. His books have been translated into French, German, Hungarian, Japanese, Portuguese, and Spanish. Dr. Levounis is married to actor Lukas Hassel and lives in New York City.

No Relevant Financial Disclosures

Ricardo Restrepo


Ricardo Restrepo, MD, MPH finished his medical school in Medellín, Colombia. He then did his residency training in Psychiatry at Boston University Medical Center where he completed a fellowship in Addiction Psychiatry. He received an MPH in Global Public Health from NYU in 2008, while working at St Luke’s/Roosevelt Hospital, where he was Director of the Addiction Psychopharmacology Clinic at the Addiction Institute of New York. 

Since 2012, he works at the Long Beach VA Hospital, where he is the Medical Director of the SATP/Buprenorphine Clinic. Ricardo holds an academic position as Associate Clinical Professor of Psychiatry at the University of California (Irvine and Riverside) School of Medicine and most recently at the Charles Drew University, Los Angeles. He teaches and supervises students, psychiatry, family medicine and internal medicine residents. He serves as committee member of the American Academy of Addiction Medicine (AAAP) as well as on the California Society of Addiction Medicine (CSAM) Conference planning committee. 

 Ricardo's academic interests include the psychotherapy and psychopharmacology of addiction and the teaching of Psychiatry and Addiction Medicine. He is actively involved in issues related to transcultural psychiatry and behavioral addictions. He has worked with immigrant populations in the United States for over 20 years. As a volunteer for Physicians for Human Rights (PHR), he has participated in projects in the United States, Latin America and the Middle East. He has served as a United Nations Consultant since 2005. 

Dr. Restrepo has written chapters on addiction and human rights textbooks. He is the co-author of textbooks on buprenorphine as well as women’s health and addiction, and he cooperated with the Translation of DSM-5 to Spanish. He is board re-certified in Psychiatry and Addiction Psychiatry and a professional musician.

No Relevant Financial Disclosures

Soteri Polydorou


Soteri Polydorou, MD is a practicing physician with board certifications in Addiction Medicine and Internal Medicine.  His involvement in the field of substance use disorder (SUD) treatment and education include serving as Medical Director of Addiction Services for Northwell Health and Associate Professor at the Zucker School of Medicine at Hofstra/Northwell.  Northwell Health is a regional health system of over 20 hospitals and nearly 800 outpatient facilities.  Dr. Polydorou is a member of various governmental and professional committees tasked with supporting the delivery and organization of addiction treatment.  Dr. Polydorou’s interests include public policy initiatives to address substance use disorders, optimizing access to SUD services within health systems, and implementation of innovative opioid use disorder treatments within various healthcare clinical settings.

No Relevant Financial Disclosures

Jonathan Avery


Jonathan Avery, MD is currently the Director of Addiction Psychiatry and an Associate Professor of Clinical Psychiatry at Weill Cornell Medical College and New York-Presbyterian Hospital. In addition to his clinical work, Dr. Avery teaches addiction psychiatry to the Weill Cornell medical students and residents of New York-Presbyterian Hospital. He has been published on a broad variety of topics in psychiatry, including papers on subjects ranging from clinician attitudes towards patients to how to use buprenorphine. He is the founder of the Addiction Stigma Institute that studies stigma towards individuals with substance use disorders and creates novel interventions to improve these stigmatizing attitudes. He was on the editorial board for the DSM-5 Clinical Cases book and is the editor of the books Co-occurring Mental Illness and Substance Use Disorders: A Guide to Diagnosis and Treatment and The Stigma of Addiction: An Essential Guide. He has won numerous awards for his clinical and academic work, including the American Board of Psychiatry and Neurology Faculty Innovation in Education Award and the Outstanding Faculty Member Award from the New York County Psychiatric Society.

No Relevant Financial Disclosures

Carla Marienfeld


Carla Marienfeld, MD, is a board-certified addiction psychiatrist and Clinical Professor at the University of California, San Diego who supports recovery in an evidence based, harm-reduction approach through therapy, motivational interviewing, and medication treatment. Her research involves analysis of electronic medical record data for individuals with substance use disorders. She has authored or co-authored over 35 peer reviewed articles, book chapters, practice guidelines, and invited commentaries, and she edited two books: Motivational Interviewing for Clinical Practice and Absolute Addiction Psychiatry Review: An essential board exam study guide. She has been highly involved in education of colleagues and trainees about addiction psychiatry and effective interventions including buprenorphine treatment and motivational interviewing, and she is the fellowship director for the UCSD Addiction Psychiatry Fellowship. Dr. Marienfeld completed a fellowship in addiction psychiatry and residency training in psychiatry at Yale. During her residency, she was chief resident of psychiatry and founded (and later led) the Yale Global Mental Health Program. She earned a medical degree with honors from Baylor College of Medicine in Houston.

Disclosures - Does Disclose:

  • Consultant and stock options: CARI Therapeutics

Michael H. Baumann


Michael H. Baumann, PhD is a Staff Scientist and Chief of the Designer Drug Research Unit (DDRU), at the Intramural Research Program (IRP) of the National Institute on Drug Abuse (NIDA) in Baltimore, Maryland.  The DDRU collects, analyzes and disseminates the most up-to-date information about the pharmacology and toxicology of newly-emerging synthetic drugs of abuse (i.e., designer drugs), more formally known as new psychoactive substances (NPS).  Working with partner organizations such as the Drug Enforcement Administration (DEA) and the National Drug Early Warning System (NDEWS), Dr. Baumann is kept informed about trends in the misuse of NPS.  The DDRU has characterized the molecular mechanism of action and pharmacological effects for a diversity of NPS, including “bath salts” (synthetic stimulants), “spice” (synthetic cannabinoids) and synthetic opioids.  Findings from the DDRU inform law enforcement personnel, health care workers, clinical toxicologists, forensic scientists, basic researchers, and policymakers who are involved in responding to the global spread of NPS and the associated public health risks. 

No Relevant Financial Disclosures

Abigail J. Herron (Moderator)


Abigail J. Herron, DO, is the Vice President of Behavioral Health and the Director of Psychiatry and Addiction Medicine at the Institute for Family Health. She is board certified in adult psychiatry, addiction psychiatry and addiction medicine, and is an Assistant Professor of Psychiatry and Family Medicine at the Icahn School of Medicine at Mt. Sinai. Dr. Herron is a fellow of the American Psychiatric Association and a Distinguished Fellow of the American Society of Addiction Medicine. She graduated from Wesleyan University and the University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine. Dr. Herron completed her psychiatry residency at St. Luke's and Roosevelt Hospitals, where she was also chief resident, and a clinical research fellowship in addiction psychiatry at Columbia University and the New York State Psychiatric Institute. Her academic interests include integrated care, women’s health, and medical education. She is the co-editor of the Addiction Casebook, and the editor-in-chief of ASAM’s Essentials of Addiction Medicine. Dr. Herron is also in private practice in New York.

Disclosures - None

Erin A. Zerbo


Erin Zerbo, MD, received her B.S. in Brain and Cognitive Sciences from the Massachusetts Institute of Technology in 2003, and her M.D. from New York University School of Medicine in 2007. She remained at NYU for a general psychiatry residency and a one-year addiction psychiatry fellowship, graduating in 2012. Since 2014, she has been an Assistant Professor in the Department of Psychiatry at Rutgers New Jersey Medical School and the Associate Director of Medical Student Education in Psychiatry. In addition to managing a large buprenorphine practice dedicated to Newark residents, she is also the director of the Northern New Jersey Center of Excellence in Medication-Assisted Treatment, a new statewide opioid training and education initiative. Dr. Zerbo serves as the co-Chair of the Council on Education of the New Jersey Psychiatric Association, and she has published and lectured extensively in the field of addiction. Her primary interest is the treatment of substance use disorders in underserved and disadvantaged populations. She is a co-editor of the book "Pocket Guide to Addiction Assessment and Treatment" (APA, 2106), and the lead editor of "Becoming Mindful: Integrating Mindfulness into Your Psychiatric Practice" (APA, 2017).

Disclosures - None

ACCME Accredited with Commendation

CME, CE, CEU and Other Credit Types

ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation
The American Society of Addiction Medicine designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA/AAFP Equivalency
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222.

California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1222.

Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit their certificate of attendance to their professional organization/institute.

Maintenance of Certification (MOC) or Continuing Certification Programs (CCP)

American Board of Medical Specialties MOC Approval Statement
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, The ASAM Virtual Review Course in Addiction Medicine has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: Allergy and Immunology, Anesthesiology, Colon and Rectal Surgery, Family Medicine, Medical Genetics and Genomics, Nuclear Medicine, Physical Medicine and Rehabilitation, Plastic Surgery, Preventive Medicine, Psychiatry and Neurology, Radiology, Thoracic Surgery, Urology.

American Board of Preventive Medicine (ABPM)
The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credits towards ABPM MOC Part II requirements.

American Board of Anesthesiology (ABA)
This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

American Board of Pediatrics (ABP)
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

American Board of Surgery (ABS)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

American Board of Psychiatry and Neurology (ABPN)
Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program. 

American Board of Addiction Medicine (ABAM)
Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

Royal College of Physicians and Surgeons of Canada (RCPSC)
Royal College Fellows can use participation in Accredited Continuing Medical Education to earn Section 3 Credits.

CME Committee, Program Planning Committee, and Faculty Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.


View On-Demand Session
Open to view video.
Open to view video. This video is approximately 60 minutes and was recorded on 7/22/2021.
Complete Post Test
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass This post-test has 3 questions and requires 2 out of 3 questions to pass the test.
Complete Evaluation
16 Questions
16 Questions Scroll down on evaluation, there may be questions that expand past the size of the window.
Claim Credit & Certificate
Up to 1.00 medical credits available  |  Certificate available
Up to 1.00 medical credits available  |  Certificate available Attendees should claim only the credit commensurate with the extent of their participation in the activity.